
The Kingston Report is an evidence-based, med-legal analysis of mRNA nanoparticle technologies, vaccines, and the dangers of the rapidly growing synthetic biology industry.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 741 | Founded | 4 years ago | Last Issue | 7 days ago |
| Active | |||||

“The data showed with over a trillion to one odds that when people experience a collective emotional response, there is a tangible effect on our physical world.”
September 15, 2026: Downtown Manhattan was part of my territory when I worked...
Mandating (or even distribution) of any the new FDA approved vaccines can be challenged under Loper Bright vs. Romando (published June 28, 2024) and Corner Post vs. Federal Reserve (July 5, 2024).
September 8, 2026: On January 31, 2025, Pr...
September 7, 2026: On September 9, 2025, Health & Human Services issued the press statement, “HHS, FDA to Require Full Safety Disclosures in Drug Ads.”
HHS Secretary Robert F. Kennedy, Jr. said, “We will shut down that pipeline of deceptio...
The FDA is now approving failed and harmful products. Ask your state representatives how they will ensure that FDA approved products will meet proper safety standards for human use.
September 2, 2026: On June 24, 2026, the Federal Register...
COVID-XFG injections are still under emergency use authorization. They don’t need to comply with human safety or efficacy laws or good manufacturing practices. Contact the FDA and state leaders.
September 1, 2026: Every few weeks I receive...
Subscribers, engagement, traffic and sponsorship for The Kingston Report.
| Subscribers | Engagement | 85 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #24 | |
| #14 |
The writers behind this newsletter.
Karen Kingston is a med-legal advisor and biotech analyst with over 25 years of experience. She's internationally recognized as an expert on the harmful biological effects caused by the COVID-19 mRNA injections and other nanobiotechnologies.
You can find recent issues that have been published by The Kingston Report on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Kingston Report, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Kingston Report as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Kingston Report using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The Kingston Report. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.